Eksplorasi Obesitas Sebagai Faktor Komorbid Covid-19: A Systematic Review

Exploration of Obesity as a Comorbid Factor of Covid-19: A Systematic Review

Authors

  • Mukhlidah Hanun Siregar Universitas Sultan Ageng Tirtayasa Author https://orcid.org/0000-0002-1402-0657
  • Mustika Arumbinang Human Nutrition Research Center (HNRC-IMERI, FKUI) Author
  • Junengsih Junengsih Politeknik Kesehatan KEMENKES III Jakarta Author

Keywords:

COVID-19, Analisa biaya, malnutrition, nutritional status, Covid-19 patients, Comorbid Disease

Abstract

Obesity is one of the comorbidities of COVID-19 which has been widely reported to have an effect on the care patients needed. This study was carried out using a Systematic Review approach to explore the effects and mechanisms that occur due to obesity in COVID-19 patients. A total of 23 articles were reviewed after selecting on various predetermined article criteria. The results shown that there was a contribution of obesity in COVID-19 patients based on the type of treatment, length of treatment, need for intensive care, severity and increased risk of death. It is recommended to maintain a healthy lifestyle while maintaining a normal weight and doing physical activity and exercise every day with a minimum duration of 30 minutes. Thus, it can reduce the accumulation of macrophages in adipose tissue, so if infect COVID-19 do not cause a cytokine storm because chronic inflammation due to obesity.

References

Mahan, L.K. 2008.Nutrition and Dietetics. Krause’s Food & Nutrition Therapy, Saunders, Philadelphia.

Dixon, A.E. and Peters, U. 2018.The effect of obesity on lung function. Expert Rev. Respir. Med. 12 (9). 755–767.

Kemenkes, R. 2014.Pedoman Gizi Seimbang. Pedoman Gizi Seimbang; Kementerian Kesehatan RI, Jakarta, 2014.

Torres, L., Martins, V., Faria, A., et al. 2018.The Intriguing Relationship Between Obesity and Infection. J. Infect. 1 (1). 6–10.

Hegde, V. and Dhurandhar, N. V. 2013.Microbes and obesity-interrelationship between infection, adipose tissue and the immune system. Clin. Microbiol. Infect. 19 (4). 314–320.

Bandaru, P., Rajkumar, H. and Nappanveettil, G. 2013.The Impact of Obesity on Immune Response to Infection and Vaccine: An Insight into Plausible Mechanisms. Endocrinol. Metab. Syndr. 02 (02). 1–9.

Marcuso, P. 2013.Obesity and respiratory infections: Does excess adiposity weigh down host defense? Pulm Pharmacol Ther 26 (4). 412–419.

Huttunen, R. and Syrjänen, J. 2013.Obesity and the risk and outcome of infection. Int. J. Obes. 37 (3). 333–340.

McArthur, L., Sakthivel, D., Ataide, R., et al. 2020.Review of burden, clinical definitions, and management of Covid-19 cases. Am. J. Trop. Med. Hyg. 103 (2). 625–638.

Albashir, A.A.D. 2020.The potential impacts of obesity on COVID-19. The potential impacts of obesity on COVID-19. Clin. Med. J. R. Coll. Physicians London 2020., 20, 109–113.

Hamer, M., Kivimäki, M., Gale, C.R., et al. 2020.Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK. Brain. Behav. Immun. 87 (May). 184–187.

Petersen, A., Bressem, K., Albrecht, J., et al. 2020.The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany. Metabolism 110 (154317). 1–11.

Bhasin, A., Nam, H., Yeh, C., et al. 2020.Is BMI Higher in Younger Patients with COVID-19? Association Between BMI and COVID-19 Hospitalization by Age. Obesity 28 (10). 1811–1814.

Gao, F., Zheng, K.I., Wang, X.B., et al. 2020.Obesity Is a Risk Factor for Greater COVID-19 Severity. Diabetes Care 43 (7). E72–E74.

Hernández-Garduño, E. 2020.Obesity is the comorbidity more strongly associated for Covid-19 in Mexico. A case-control study. Obes. Res. Clin. Pract. 14 (4). 375–379.

Moriconi, D., Masi, S., Rebelos, E., et al. 2020.Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding. Obes. Res. Clin. Pract. 14 (3). 205–209.

de Lusignan, S., Dorward, J., Correa, A., et al. 2020.Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. Lancet Infect. Dis. 20 (9). 1034–1042.

Ebinge, J.E., Achamallah, N., Ji, H., et al. 2020.Pre-existing traits associated with Covid-19 illness severity. PLoS One 15 (7 July). 1–16.

Kammar-García, A., de Vidal-Mayo, J.J., Vera-Zertuche, J.M., et al. 2020.Impact of comorbidities in Mexican SARS-CoV-2-positive patients: A retrospective analysis in a national cohort. Rev. Investig. Clin. 72 (3). 151–158.

Price-Haywood, E.G., Burton, J., Fort, D., et al. 2020.Hospitalization and Mortality among Black Patients and White Patients with Covid-19. N. Engl. J. Med. 382 (26). 2534–2543.

Hernández-Galdamez, D.R., González-Block, M.Á., Romo-Dueñas, D.K., et al. 2020.Increased Risk of Hospitalization and Death in Patients with COVID-19 and Pre-existing Noncommunicable Diseases and Modifiable Risk Factors in Mexico. Arch. Med. Res. 51 (7). 683–689.

Kalligeros, M., Shehadeh, F., Mylona, E.K., et al. 2020.Association of Obesity with Disease Severity Among Patients with Coronavirus Disease 2019. Obesity 28 (7). 1200–1204.

Ortiz-Brizuela, E., Villanueva-Reza, M., González-Lara, M.F., et al. 2020.Clinical and Epidemiological Characteristics of Patients Diagnosed With Covid-19 in a Tertiary Care Center in Mexico City: a Prospective Cohort Study. Rev. Invest. Clin. 72 (3). 165–177.

Simonnet, A., Chetboun, M., Poissy, J., et al. 2020.High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity 28 (7). 1195–1199.

Klang, E., Kassim, G., Soffer, S., et al. 2020.Severe Obesity as an Independent Risk Factor for COVID?19 Mortality in Hospitalized Patients Younger than 50. Obesity 28 (9). 1595–1599.

Busetto, L., Bettini, S., Fabris, R., et al. 2020.Obesity and COVID-19: An Italian Snapshot. Obesity 28 (9). 1600–1605.

Escalera-Antezana, J.P., Lizon-Ferrufino, N.F., Maldonado-Alanoca, A., et al. 2020.Risk factors for mortality in patients with coronavirus disease 2019 (COVID-19) in Bolivia: An analysis of the first 107 confirmed cases. Infez. Med. 28 (2). 238–242.

Hu, X., Pan, X., Zhou, W., et al. 2020.Clinical epidemiological analyses of overweight/obesity and abnormal liver function contributing to prolonged hospitalization in patients infected with COVID-19. Int. J. Obes. 44 (8). 1784–1789.

Petrilli, C.M., Jones, S.A., Yang, J., et al. 2020.Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 369 (m1966). m1966.

Sattar, N., Ho, F.K., Gill, J.M., et al. 2020.BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: Preliminary findings from UK biobank. Diabetes Metab. Syndr. Clin. Res. Rev. 14 (5). 1149–1151.

Deng, M., Qi, Y., Deng, L., et al. 2020.Obesity as a Potential Predictor of Disease Severity in Young COVID-19 Patients: A Retrospective Study. Obesity 28 (10). 1815–1825.

Palaiodimos, L., Kokkinidis, D.G., Li, W., et al. 2020.Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism 108 (January). 154262.

Giacomelli, A., Lisa, A., Milazzo, L., et al. 2020.30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study. Pharmacol. Res. 158 (104931). 1–7.

Muhammad, H.F.L. 2021.Imunologi Gizi. Imunologi Gizi; UGM Press, Yogyakarta, 2021.

Caspar-Bauguil, S., Cousin, B., Galinier, A., et al. 2005.Adipose tissues as an ancestral immune organ: Site-specific change in obesity. FEBS Lett. 579 (17). 3487–3492.

Weisberg, S.P., McCann, D., Desai, M., et al. 2003.Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (12). 1796–1808.

Sharma, J.R. and Yadav, U.C.S. 2021.COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention. Obes. Res. Clin. Pract. 15 (2). 163–171.

Roschewski, M., Lionakis, M.S., Sharman, J.P., et al. 2020.Inhibition of Bruton tyrosine kinase in patients with severe COVID-19. Sci. Immunol. 5 (48). 1–18.

Mangalmurti, N. and Hunter, C.A. 2020.Cytokine Storms: Understanding COVID-19. Immunity 53 (1). 19–25.

Downloads

Published

2022-10-31

Issue

Vol. 4 No. 5 (2022): J. Sains Kes.

Section

Review

How to Cite

[1]
M. H. Siregar, M. Arumbinang, and J. Junengsih, “Eksplorasi Obesitas Sebagai Faktor Komorbid Covid-19: A Systematic Review: Exploration of Obesity as a Comorbid Factor of Covid-19: A Systematic Review”, J. Sains. Kes, vol. 4, no. 5, pp. 540–547, Oct. 2022, Accessed: Nov. 23, 2025. [Online]. Available: http://jsk.ff.unmul.ac.id/index.php/JSK/article/view/555

Similar Articles

61-70 of 145

You may also start an advanced similarity search for this article.